ResearcherUniversity at Buffalo, State University of New YorkNo recent work listed
Sailee Suryakant Rasam
Matched on ORCID iD 0000-0001-8051-8034; OpenAlex author ID A5032723676. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2022: 1 paper · 2023: 1 paper
Papers 2
- Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Novel Combination Drug Therapy That Induces… Co-author DOI 10.1021/acs.jproteome.3c00463↗
- Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.1016/j.mcpro.2022.100409↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jun Qu · 2 shared papers, 2022–2023 · strength 0.39
- Paper Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Nov… DOI 10.1021/acs.jproteome.3c00463↗
- Paper Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1016/j.mcpro.2022.100409↗
- Qingxiang Lin · 2 shared papers, 2022–2023 · strength 0.39
- Paper Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Nov… DOI 10.1021/acs.jproteome.3c00463↗
- Paper Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1016/j.mcpro.2022.100409↗
- Robert M. Straubinger · 2 shared papers, 2022–2023 · strength 0.39
- Paper Highly Reproducible Quantitative Proteomics Analysis of Pancreatic Cancer Cells Reveals Proteome-Level Effects of a Nov… DOI 10.1021/acs.jproteome.3c00463↗
- Paper Comparative Proteomic Analysis Identifies Key Metabolic Regulators of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.1016/j.mcpro.2022.100409↗
- William J. Jusko · 1 shared paper, 2022 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.